In this episode, experts from North Carolina - Dr. Carrie Brown, Dr. Charlene Wong, and Dr. Gary Maslow - discuss the current state of pediatric behavioral health, why it's important, some programs addressing today’s challenges, and lessons for how we give the next generation a better mental health future.

In this episode, Carmel Shachar, JD, MPH, of the Center for Health Law and Policy Innovation at Harvard Law School, joins Regan Murphy to explore the role of Artificial Intelligence in Utilization Management – what it is, why it’s important, and where policy still needs to evolve.

Dr. Rob Bessler and Regan Murphy dig into the ACO REACH model, what it is, how it fits into CMS' strategy, how it compares to other ACO models, what impact the model has made, where it needs to evolve, and how can policy makers do to better support providers adopting value-based care frameworks.

In this episode, Roy Ramthun and Regan Murphy get into Health Savings Accounts (HSAs), what they are & are not, what advice he has for consumers, and where HSA policy can go from here in the face of ever-rising health premiums and costs.

In this episode, Josh Morrison and Regan Murphy discuss challenges to vaccine development, what are some lessons learned from Operation Warp Speed and across other industries that could help, and where we go from here to be ready for the next public health challenge.

In this episode, Abe Sutton and Dr. Ben Miller discuss why people struggle to find behavioral health providers and explore policy solutions to expand the behavioral health workforce.

In this episode, host Abe Sutton sits down with Gabe Drapos, COO of Pearl Health, to explore how the health status of Medicare beneficiaries influences payments from the government to Medicare Advantage plans. They discuss the current mechanisms behind these adjustments and dive into a proposal they coauthored in Health Affairs outlining potential reforms to create a fairer system.

On this episode of At The Crossing, host Abe Sutton and guest Theo Merkel discuss how Medicare Part B sets prices for new drugs and a proposal Theo authored to use market forces to negotiate rates.